Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh
· Delayed Price · Currency is BDT 28.60
+0.60 (2.14%)
At close: Dec 3, 2025
Orion Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -540.39 | -415.28 | 318.12 | 640.94 | 846.08 | 939.06 | Upgrade
|
| Depreciation & Amortization | 565.89 | 634.4 | 588.7 | 601.12 | 498.45 | 1,019 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0 | 0 | 2.86 | -0.21 | -0.08 | 5.93 | Upgrade
|
| Other Operating Activities | 437.42 | 425.53 | 432.84 | 256.66 | -225.31 | 528.16 | Upgrade
|
| Change in Accounts Receivable | 132.51 | -388.27 | 1,319 | 1,004 | -2,841 | -1,448 | Upgrade
|
| Change in Inventory | 240 | 192.79 | -96.04 | 45.45 | -263.32 | -133.11 | Upgrade
|
| Change in Accounts Payable | 36.6 | 667.23 | -1,134 | -327.19 | 3,226 | 1,603 | Upgrade
|
| Change in Other Net Operating Assets | -49.85 | -12.27 | 155.36 | 272.12 | -79.3 | 77.52 | Upgrade
|
| Operating Cash Flow | 822.18 | 1,104 | 1,587 | 2,493 | 1,162 | 2,592 | Upgrade
|
| Operating Cash Flow Growth | -25.93% | -30.41% | -36.36% | 114.60% | -55.17% | 37.68% | Upgrade
|
| Capital Expenditures | -37.69 | -767.16 | -1,948 | -3,859 | -2,667 | -4,277 | Upgrade
|
| Sale of Property, Plant & Equipment | 152.21 | 152.21 | 371.11 | - | - | - | Upgrade
|
| Cash Acquisitions | -69.82 | -62.94 | 386.09 | -1,376 | -379.31 | -1,633 | Upgrade
|
| Investment in Securities | -8.36 | -8.36 | -0.22 | 0.01 | -8.6 | 0.03 | Upgrade
|
| Other Investing Activities | 13.29 | 13.45 | 24.06 | 27.28 | 19.68 | 45.44 | Upgrade
|
| Investing Cash Flow | 49.63 | -672.8 | -1,167 | -5,208 | -3,035 | -5,864 | Upgrade
|
| Short-Term Debt Issued | - | - | 16.21 | 11.2 | 387.98 | 392.27 | Upgrade
|
| Long-Term Debt Issued | - | - | 764.9 | 3,311 | 1,784 | 3,131 | Upgrade
|
| Total Debt Issued | -428.3 | - | 781.11 | 3,322 | 2,172 | 3,523 | Upgrade
|
| Short-Term Debt Repaid | - | -62.48 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -281.23 | -22.33 | -28.36 | -33.66 | -40.63 | Upgrade
|
| Total Debt Repaid | -317.58 | -343.71 | -22.33 | -28.36 | -33.66 | -40.63 | Upgrade
|
| Net Debt Issued (Repaid) | -745.88 | -343.71 | 758.78 | 3,293 | 2,138 | 3,482 | Upgrade
|
| Common Dividends Paid | -3.41 | -8.21 | -269.9 | -152.94 | -324.54 | -340.17 | Upgrade
|
| Dividends Paid | -3.41 | -8.21 | -269.9 | -152.94 | -324.54 | -340.17 | Upgrade
|
| Other Financing Activities | -183.3 | -155.04 | -890.42 | -401.76 | -249.56 | -488.68 | Upgrade
|
| Financing Cash Flow | -932.59 | -506.96 | -401.55 | 2,739 | 1,564 | 2,654 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | 0 | 0 | -0 | 0 | -0 | Upgrade
|
| Net Cash Flow | -60.78 | -75.63 | 17.62 | 23.97 | -308.86 | -619.18 | Upgrade
|
| Free Cash Flow | 784.49 | 336.97 | -361.87 | -1,366 | -1,505 | -1,685 | Upgrade
|
| Free Cash Flow Margin | 24.29% | 8.25% | -3.41% | -9.81% | -15.58% | -15.56% | Upgrade
|
| Free Cash Flow Per Share | 3.35 | 1.44 | -1.55 | -5.84 | -6.43 | -7.20 | Upgrade
|
| Cash Interest Paid | 176.24 | 155.04 | 890.42 | 401.76 | 249.56 | 488.68 | Upgrade
|
| Cash Income Tax Paid | 44.41 | 45.65 | 194.54 | 117.03 | 95.73 | 40.91 | Upgrade
|
| Levered Free Cash Flow | 208.33 | 269.21 | -618.16 | -3,066 | -1,366 | -36.58 | Upgrade
|
| Unlevered Free Cash Flow | 491.51 | 539.14 | -372.3 | -2,974 | -1,257 | 103.06 | Upgrade
|
| Change in Working Capital | 359.26 | 459.48 | 244.04 | 994.67 | 42.63 | 99.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.